Program name:  Summer Student Research Scholarships in Psoriatic Diseases

Funding organizations:  Canadian Association of Psoriasis Patients (CAPP), Janssen Inc., Canadian Institutes of Health Research-Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA)

Application Deadline: Friday, February 17th, 2017

Anticipated Notice of Decision: March 31st, 2017

Funding Start Date: May 1st, 2017

Description

The purpose of this funding opportunity is to provide undergraduate and health professional students with opportunities to undertake research projects related to psoriatic diseases with established investigators in an environment that provides strong mentorship.

Funds Available

The total amount available for this funding opportunity is $25,000 (up to 5 awards.) The number of awards may increase if additional funding partners participate.  The maximum stipend contribution per award is $5,000 for four months.

Objectives

This opportunity targets the early stage of the student’s academic training to encourage the pursuit of a career in psoriatic disease research.

Eligibility to Apply

For your application to be eligible:

  1. The Nominated Principal Applicant must be a trainee. The trainee must meet the following requirements:
    1. Enrollment in a medical school program at a Canadian university at the time of application.
    2. Have completed the course requirements of at least the first year of university study (or two academic terms) by the funding start date.
  2. At least one project participant must be a Primary supervisor. The Supervisor must meet the following requirements:
    1. Be employed by a Canadian institution considered eligible under CIHR's guidelines. Please see CIHR's Grants and Awards Guide for more information.
    2. If a Supervisor is affiliated with more than one application, each application must contain a separate and distinct research project.
  3. The application must meet the specific requirements described below

Guidelines:

Official Languages

Applicants can submit proposals in the Official Language of their choice and we are committed to ensuring high quality review of applications submitted in either Official Language.

Allowable Costs

The awards consist of a stipend.

Awardees should review the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Financial Administration Guide for a complete listing and description of allowable costs and activities.

Conditions of Funding

Successful applicants funded through this funding opportunity and any other persons working on the project must comply fully with the CIHR Funding Policies. Policies and guidelines cover areas such as Applicant Responsibilities, Official Languages policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR's Support. Successful applicants will be informed of any special financial requirements prior to the release of funds.

Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)

All personal information collected about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by this application may be shared as described in the Conflict of Interest and Confidentiality Policy of the Federal Research Funding Organizations.

While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Funding opportunity will be collected, used and disclosed in compliance with the PIPEDA.

Communication Requirements

Funding recipients are required to acknowledge the Canadian Association of Psoriasis Patients, CIHR-IMHA and industry partners in any communication or publication related to the project. See Communication of Competition Results for details on CIHR’s communication requirements. The contributing collaborators/partners will be identified on the decision letter.

Review Process and Evaluation:

Relevance Review Process

This award is to fund applications that are specific to psoriatic disease research.  Applications that are not deemed to be relevant to psoriatic diseases will be withdrawn from the competition.  Relevancy review will take place at the same time as the adjudication of the application by the review panel.

Review Committee

Applications will be reviewed by a Committee selected based on expertise in this area.  Members will follow the Conflict of Interest and Confidentiality Policy of the Federal Research Funding Organizations.

Evaluation Criteria

Eligible applications will be evaluated using the following review criteria:

  • Academic excellence and research interests of the student;
  • Excellence of the research project and relevance to psoriatic diseases;
  • Quality of the mentoring plan and training environment;
  • Suitability of the supervisor and appropriateness of the student for the award;
  • The track record of the supervisor as a principal investigator in psoriatic disease research

Funding Decision

Upon completion of the review, CAPP will receive the ratings for the applications from the Committee.  Applications will be funded from the top down in order of ranking as far as the budget will allow.

How to Apply

The application must be a single PDF document, minimum 12 font, single spaced, with one inch margins consisting of the following sections:

1. Student/supervisor/project information page (Front page:  maximum one page):  List the following information:  A. Project title.  B. Student’s name and status in current academic program.  C. Supervisor’s name and current employment.  D. Research activity location F. Funding period requested. G. Signatures of both student and supervisor.

1.  Summary of project (maximum one page):  Describe the project, hypothesis, and specific objectives that the trainee will undertake.

2. Relevance to psoriatic arthritis: (maximum ½ page):  Note that only projects relevant to psoriatic arthritis will be funding.

3. Lay title and lay summary (maximum ½ page):  This section should be suitable for a press release and/or for the CAPP website to attract donors.

3. Mentorship plan (maximum one page):    Supervisor should outline the research activities of the student, detail a mentoring plan that will enable the student to achieve these objectives, and specify which funds will be used to support the research.  Details should include who will directly supervise the student, how often the student will meet with the supervisor, and plans for the student to present their research. Importantly, the specific funding agency, the title of the grant, and the fund number of the grant used to support this research should be detailed.

4. CV of student (maximum 5 pages): Summarize current academic and research achievements.  List all research presentations, abstracts and publications.

5. CV of supervisor (maximum 5 pages, limit publications and funding history to last 5 years): Summarize academic and/or employment history.  List all publications and funding in the last five years.  Include a section detailing significant contributions to the field of psoriatic arthritis.

6. Student transcripts:  Student transcripts should be scanned, converted to PDF documents and appended to the document.  Official transcripts from the University should be sent directly to Kathryn Andrews-Clay, Executive Director, Canadian Association of Psoriasis Patient, 15 Capella Court, Unit 109, Ottawa, ON, K2E 7X1

Specific Conditions of Funding/Knowledge Translation

The candidates, at the end of the funding period are invited to submit a 3 minute video (maximum) succinctly describing their research and its relevance to psoriatic research. Deadline to submit for these videos is September 29th, 2017.   The videos will be judged by the funding partners/CAPP Board and the best two videos will each be granted $2,000 travel awards specifically to reimburse travel and registration costs involved in presenting their research at an international conference.   These videos must be aimed at a general lay audience with limited scientific expertise as they will also be uploaded on the CAPP website to encourage further donations to support psoriatic research.  For examples of 3 minute videos of research aimed at general audiences, follow the link below to see videos from last year’s students:

https://www.youtube.com/watch?v=xfv9gOPEcww&list=PL6l0E_CBR89cmGJYFU3RXUsY9Ekpb7dvk

Contact Information

For questions on how to apply, and the peer review process contact:

Kathryn Andrews-Clay

Executive Director,

Canadian Association of Psoriasis Patients

15 Capella Court, Unit 109, Ottawa, ON   K2E 7X1

613-294-1484

Sponsor Descriptions:

Canadian Association of Psoriasis Patients

The Canadian Association of Psoriasis Patients was formed to better serve the needs of psoriasis patients across the country.  We are a subsidiary of the Canadian Skin Patient Alliance and strive to improve the quality of life for all Canadian psoriasis patients.  Our mission is to be a resource for psoriasis patients and their families by providing support and education and raising awareness about the effects of psoriasis to improve patient care and quality of life.

Janssen Inc.

Janssen Inc., a pharmaceutical company of Johnson & Johnson, has been an innovator in the Canadian healthcare industry for over 50 years, where their first responsibility is to the doctors, nurses and patients, and mothers and fathers, and all others who use our products and services. Their ultimate goal is to help people live healthy lives.

CIHR Institute of Musculoskeletal Health and Arthritis (IMHA)
IMHA's mission reflects that of CIHR's - to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge in all areas relevant to arthritis, musculoskeletal (MSK) rehabilitation, bone, muscle, skin and oral health, and to translate that new knowledge into improved health for Canadians, more effective health services and products, and a strengthened Canadian health care system.